Other News To Note
• NeoStem Inc., of New York, said it was awarded a two-year grant totaling $1.2 million to study the repair of bone defects with human autologous pluripotent very small embryonic-like (VSEL) stem cells from the National Institute of Dental and Craniofacial Research.
